ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

pharmafile | November 10, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. Franz Humer arrives with a wealth of industry experience after having worked as chief executive officer and chairman of Roche for 16 years. He is currently a chairman of Biageo and a non-exeuctive director of Citigroup, Kite Pharma and Chugai Pharmaceutical.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz’s stature. His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally. Franz further strengthens a very experience board of executive and non-executive directors.”

Franz Humer said: “Arix Bioscience offers a much needed new approach to supporting innovation in our industry. Its team has outstanding breadth of expertise in nurturing promising start ups, broad operating skills and a strong track record in creating and developing successful companies in the healthcare and life science sector with scope to offer significant patient benefit. I look forward to working with the Board and supporting the executive team in building the Arix business and helping to realise substantial value for shareholders.”

Advertisement

Related Content

No items found
The Gateway to Local Adoption Series

Latest content